Biomeme, Inc. was founded with the vision of enabling anyone, anywhere, to explore the biological world. Since inception, Biomeme has used advanced biology and chemistry along with world-class hardware and software engineering to create elegant solutions to complex problems. Biomeme has built the leading mobile molecular diagnostics platform, and recently used its platform to develop a portable test solution to detect SARS-CoV-2, the virus that causes COVID-19.

COMPANY HIGHLIGHTS

• Leading provider of portable PCR testing solutions, major entertainment industry customers.
• Strong IP and newly acquired future-of-medicine early disease detection company Predigen.